Overview & Epidemiology - Golden Year Jitters
- Prevalence: Significant, affecting 10-20% of elderly; often underdiagnosed.
- Not normal aging; distinct from dementia-related behavioral changes.
- Risk Factors: Female, chronic illness, disability, social isolation, bereavement, polypharmacy, cognitive decline.
- Most Common:
- Generalized Anxiety Disorder (GAD)
- Phobias (e.g., agoraphobia)
- Impact: ↓ Quality of Life, ↑ disability & healthcare use.
⭐ Generalized Anxiety Disorder (GAD) is the most common anxiety disorder in late life (prevalence up to 7%), frequently underdiagnosed or misattributed.
Risk Factors & Etiology - Roots of Restlessness
- Biological: Neurotransmitter imbalance (↓GABA, ↓Serotonin, ↑NE), HPA axis hyperactivity, genetics, age-related brain changes.
- Medical/Physical:
⭐ Chronic medical conditions (e.g., cardiovascular disease, COPD, chronic pain) and polypharmacy are significant risk factors for late-life anxiety.
- Sensory impairment (vision/hearing).
- Neurological disorders (dementia, stroke).
- Poor sleep quality.
- Psychosocial: Loss (bereavement, independence, role), social isolation, financial strain, elder abuse, caregiver stress.
- Cognitive/Psychological: Fear of decline/illness/death, personality (neuroticism), past anxiety history.
oka
Clinical Features & Diagnosis - Subtle Signs, Silent Screams
- Atypical presentations common: "anxiety equivalents".
- Somatic: Chronic pain, fatigue, GI issues, palpitations, insomnia.
- Cognitive: Persistent worry, ↓concentration, memory complaints (≠ dementia).
- Behavioral: Irritability, agitation, withdrawal, ↑dependency.
- Challenges:
- Underreporting (stigma, "normal aging" belief).
- Symptom overlap: medical illness, polypharmacy SEs.
- Diagnosis:
- Thorough history (patient, caregiver).
- Rule out organic causes.
- Screening: GAD-7 (adapted).
- DSM-5 criteria, considering age-specifics.
⭐ Anxiety in older adults frequently presents with somatic symptoms (e.g., pain, fatigue, GI distress) and cognitive complaints, often leading to misattribution or overshadowing by other medical conditions.

Management Approaches - Calming the Twilight Storm
- Non-Pharmacological (First-Line):
- Psychotherapy: CBT, supportive therapy, relaxation techniques.
- Lifestyle: Regular exercise, social engagement, sleep hygiene.
- Pharmacological (📌 Start low, go slow):
- SSRIs: Escitalopram, Sertraline (preferred).
- SNRIs: Venlafaxine, Duloxetine.
- Buspirone: Consider for augmentation.
- ⚠️ Benzodiazepines (e.g., Lorazepam): Short-term ONLY for acute distress. High risk: falls, cognitive decline, paradoxical agitation.
- Avoid: Tricyclic antidepressants (TCAs), long-acting BZDs.
⭐ SSRIs (e.g., escitalopram, sertraline) are first-line pharmacotherapy for anxiety in the elderly; benzodiazepines should be used with extreme caution (short-term only, if necessary) due to risks of falls, cognitive impairment, and paradoxical agitation. (📌 Start low, go slow)
High‑Yield Points - ⚡ Biggest Takeaways
- GAD and phobias are the most common anxiety disorders in the elderly.
- Presentation is often dominated by somatic complaints rather than psychological symptoms.
- High comorbidity exists with depression and cognitive decline.
- Risk factors include chronic medical conditions, polypharmacy, and social isolation.
- SSRIs are first-line treatment; always start low, go slow.
- Use benzodiazepines cautiously due to risks of falls and cognitive impairment.
- CBT and supportive therapy are key non-pharmacological treatments.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app